DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Compugen Ltd. (CGEN)
« Back to company indexCGEN Chatter Timeline
Stock Ticker for CGEN
Most Active Tweeters for CGEN
| User | Tweets |
|---|---|
| @AmericanBanking | 6 |
| @bulletin_en | 5 |
| @TranscriptDaily | 3 |
| @StockNewsNow | 2 |
| @WKRBNews | 2 |
Recent Tweets for CGEN
 |
@TranscriptDaily Compugen $CGEN Stock Rating Upgraded by Zacks Investment Research https://t.co/YypzLNXeqw May 23rd 2019, 7:05pm |
 |
@AmericanBanking Compugen Ltd. Forecasted to Earn Q2 2019 Earnings of -$0.13 Per Share $CGEN https://t.co/BT5Yn6jHiC #stocks May 23rd 2019, 6:05am |
|
@AmericanBanking Jefferies Financial Group Equities Analysts Cut Earnings Estimates for Compugen Ltd. $CGEN https://t.co/yeISNiRlQp #stocks May 23rd 2019, 6:05am |
 |
@WKRBNews Analysts Offer Predictions for Compugen Ltd.’s Q1 2020 Earnings $CGEN https://t.co/uJ0gNBYvfL #markets May 23rd 2019, 1:05am |
 |
@StockNewsNow $CGEN Compugen to Present at the Jefferies 2019 Healthcare Conference https://t.co/lEf4edeakB May 22nd 2019, 10:05am |
|
@AmericanBanking Q1 2020 Earnings Estimate for Compugen Ltd. Issued By Oppenheimer $CGEN https://t.co/tIHeEKxgpc #stocks May 22nd 2019, 8:05am |
 |
@macondailynews Q1 2020 Earnings Estimate for Compugen Ltd. Issued By Oppenheimer $CGEN https://t.co/R1eCG7RlYu May 22nd 2019, 8:05am |
 |
@RatingsNetwork Oppenheimer Sets Compugen Q1 2020 Earnings Estimates at ($0.11) EPS. https://t.co/4SwQDbmn46 $CGEN #CGEN May 22nd 2019, 8:05am |
|
@WKRBNews Compugen $CGEN Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS https://t.co/tDZqsxt0aw #markets May 22nd 2019, 8:05am |
 |
@bulletin_en Contrasting of Abeona Therapeutics Inc. $CGEN https://t.co/ZUGpsV1pq0 May 21st 2019, 8:05pm |
 |
@BioTuesdays $CGEN Compugen doses first patient in advanced solid tumor trial https://t.co/jh6ehE73NC May 21st 2019, 12:05pm |
 |
@dakotafinancial Compugen $CGEN Issues Quarterly Earnings Results, Beats Estimates By $0.03 EPS https://t.co/tmzJbpQxh4 May 21st 2019, 8:05am |
|
@TranscriptDaily Compugen $CGEN Announces Earnings Results https://t.co/WKbuiz9jHD May 21st 2019, 7:05am |
 |
@stocknewstimes Compugen $CGEN Announces Quarterly Earnings Results, Beats Estimates By $0.03 EPS https://t.co/aCZsHQvR4s May 21st 2019, 7:05am |
 |
@SleekMoneycom Compugen $CGEN Announces Quarterly Earnings Results, Beats Estimates By $0.03 EPS https://t.co/eviYD6h9Mh #investing May 21st 2019, 7:05am |
|
@AmericanBanking Compugen $CGEN Posts Earnings Results, Beats Estimates By $0.03 EPS https://t.co/6o0Y1E8UeZ #stocks May 21st 2019, 7:05am |
 |
@OlympiaReport Head to Head Survey: Voyager Therapeutics $VYGR versus Compugen $CGEN https://t.co/KhHKn4KaHZ May 21st 2019, 1:05am |
 |
@SiteFocusHQ $CGEN Qualitative Analysis of recent earnings identified Compugen Ltd. (NASDAQ: SUMR ) business focus on (drug,immu… https://t.co/HV32jdB3MX May 20th 2019, 1:05pm |
 |
@SeekingAlpha $CGEN - Compugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q1 2019 Results - Earnings Call Transcript https://t.co/s6hV7OFuhn May 20th 2019, 12:05pm |
|
@StockNewsNow $CGEN Compugen Doses First Patient in COM701/Opdivo® (Nivolumab) Combination Arm of Phase 1 Study in Patients With… https://t.co/voilYGVvmK May 20th 2019, 11:05am |
|
@bulletin_en Compugen $CGEN Gets BidaskScore Higher Rating; Cohen & Steers Select Preferred & Income Fund $PSF Has 1.09 Sentiment https://t.co/Mla6pzLk9I May 20th 2019, 10:05am |
 |
@StockNewsWires $CGEN: Compugen begins patient dosing in early-stage Cancer study: https://t.co/u1EKs3Lsgq May 20th 2019, 8:05am |
 |
@MarketCurrents $CGEN - Compugen begins patient dosing in early-stage Cancer study https://t.co/CzJCLu5HKn May 20th 2019, 8:05am |
 |
@HottestStockNow The Real Numbers Behind $CGEN Revealed https://t.co/WqYxrxzHAG May 20th 2019, 8:05am |
 |
@StockTexts $CGEN Compugen Ltd. SEC Filing: Form 6-K https://t.co/CDLbCsaFic May 20th 2019, 7:05am |
 |
@bthefirsttoknow $CGEN Compugen Doses First Patient in COM701/Opdivo® (Nivolumab) Combination Arm of Phase 1 Study in Patients With… https://t.co/LktsM2GGFX May 20th 2019, 7:05am |
 |
@newswithvalue $AZZ $CGEN: Earnings Scheduled For May 20, 2019: https://t.co/4k93RDDF6x May 20th 2019, 4:05am |
 |
@ZolmaxNews Head to Head Survey: Compugen $CGEN vs. Sutro Biopharma $STRO https://t.co/yG0NCljYDE May 20th 2019, 3:05am |
 |
@MarketChmln $CGEN to report earnings on May 20 BMO, with an expected move of ±11.3% https://t.co/ccd9VnUUAi May 19th 2019, 11:05pm |
|
@TranscriptDaily Compugen $CGEN to Release Quarterly Earnings on Monday https://t.co/E5NwNhEn6o May 19th 2019, 1:05am |
|
@AmericanBanking Compugen $CGEN and Sutro Biopharma $STRO Head-To-Head Comparison https://t.co/Z9G98kxW7n #stocks May 15th 2019, 4:05pm |
 |
@TickerReport Sutro Biopharma $STRO and Compugen $CGEN Head-To-Head Comparison https://t.co/8oFvTcESCR May 15th 2019, 4:05pm |
 |
@ChartMill $CGEN has a bad technical rating, but it does show a decent setup pattern. https://t.co/6TUI9Bqnsp https://t.co/m13r0xqBHu May 15th 2019, 9:05am |
|
@bulletin_en Reviewing GlycoMimetics Inc. $CGEN's results https://t.co/xr5jGcERjN May 15th 2019, 12:05am |
|
@ZolmaxNews Zacks: Analysts Expect Compugen Ltd. $CGEN to Post -$0.17 EPS https://t.co/yzfB1H7S0Y May 14th 2019, 4:05pm |
|
@bulletin_en Reviewing Amicus Therapeutics Inc. $CGEN's results https://t.co/yWV0REgSAX May 13th 2019, 11:05pm |
|
@bulletin_en Comparison of Axovant Sciences Ltd. $CGEN https://t.co/i9IkDnQFvz May 13th 2019, 9:05pm |
|
@AmericanBanking Compugen $CGEN Scheduled to Post Quarterly Earnings on Monday https://t.co/ER1e8FrRu1 #stocks May 13th 2019, 2:05am |
 |
@bbnsnews Brokerages Expect Compugen Ltd. $CGEN to Post -$0.17 EPS https://t.co/mnzKrxiLY4 May 7th 2019, 6:05pm |
|
@AmericanBanking Zacks: Brokerages Expect Compugen Ltd. $CGEN Will Announce Earnings of -$0.17 Per Share https://t.co/dmmocTmGJY #stocks May 7th 2019, 6:05pm |
 |
@FinZTribune Radius Health Inc. $CGEN Comparison side by side https://t.co/9vemqPZLme May 5th 2019, 5:05pm |
|
@FinZTribune Reviewing Ovid Therapeutics Inc. $CGEN's results https://t.co/1udXCtuqso May 3rd 2019, 7:05pm |
 |
@dispatchtribune Compugen $CGEN Stock Rating Lowered by Zacks Investment Research https://t.co/oLT26v78UM May 3rd 2019, 12:05pm |
 |
@israeli_bulls $CGEN the bear pattern is confirmed & a SHORT signal is issued @ https://t.co/pQs9rdomHl. Short Level: 1235.9400 Target: 1161.78 May 1st 2019, 11:05am |
|
@dakotafinancial Compugen $CGEN Downgraded by Zacks Investment Research to “Hold” https://t.co/hIwvdpgzcE May 1st 2019, 9:05am |
|
@OlympiaReport Compugen $CGEN Lowered to “Hold” at Zacks Investment Research https://t.co/IjUPyrbfPp April 30th 2019, 8:04pm |
|
@israeli_bulls $CGEN may go down 6% if the bear pattern is confirmed. Chk confirmation [70%] @ https://t.co/pQs9rdomHl. Short level:1252.0000. April 30th 2019, 11:04am |
|
@OlympiaReport -$0.17 Earnings Per Share Expected for Compugen Ltd. $CGEN This Quarter https://t.co/csRMVDWrsa April 22nd 2019, 9:04pm |
 |
@TheMarketsDaily Compugen Ltd. $CGEN Expected to Announce Earnings of -$0.17 Per Share https://t.co/wbQoQjbo6x April 20th 2019, 12:04pm |
|
@stocknewstimes Compugen Ltd. $CGEN Expected to Announce Earnings of -$0.17 Per Share https://t.co/jH7hC92Dfy April 20th 2019, 12:04pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.